Logo

Chris Coughlin

Mar 02, 2016

Hologic has appointed Chris Coughlin to its board of directors. He currently serves on the boards of Allergan (formerly Actavis), Alexion Pharmaceuticals, and Dun & Bradstreet, where he is chairman of the board. Coughlin has held executive operating and financial positions at the Interpublic Group, Pharmacia, and Nabisco International. He previously served on the boards of Covidien, Dipexium Pharmaceuticals, Forest Laboratories, the Interpublic Group, Monsanto, and Perrigo.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.